Development of a French epidemiological surveillance system of workers producing or handling engineered nanomaterials in the workplace

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 6 SUPPL., 2011, Pages

  Boutou Kempf, Odile ^a   Marchand, Jean Luc ^a   Radauceanu, Anca ^b   Witschger, Olivier ^b   Imbernon, Ellen ^a   Andre J C ^c   Bloch, D ^c   Boczkowski, J ^c   Brochard, P ^c   Chevallier, R ^c   Dab, W ^c   Fontaine, M ^c   Goldberg, M ^c   Honnert, B ^c   Luce, D ^c   Maisonneuve, P ^c   Maladry, P ^c   Marano, F ^c   Nadif, R ^c   Pairon, J C ^c   Spira, A ^c   Thieriet, N ^c   more..

^a French Institute for Public Health Surveillance   (France)

^b INSTITUT NATIONAL DE RECHERCHE ET DE SÉCURITÉ   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

NANOMATERIAL;

ADVERSE OUTCOME; BIOSURVEILLANCE; COHORT ANALYSIS; FRANCE; HUMAN; NANOTECHNOLOGY; NONHUMAN; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; QUANTITATIVE ANALYSIS; REVIEW;

EID: 79959240682     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31821b1d68     Document Type: Review

References (25)

1. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622-627. (Pubitemid 43191298)
2. Thacker SB, Stroup DF, Parrish RG, Anderson HA. Surveillance in environmental public health: issues, systems, and sources. Am J Public Health. 1996;86:633-638. (Pubitemid 26145474)
3. International Organization for Standardization. ISO/TS 27687: Nanotechnologies-terminology and definition for nano-objects - nanoparticle, nanofibre and nanoplate. Geneva: ISO; 2008:1-7.
4. Oberdorster G, Maynard A, Donaldson K et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2005;2:8.
5. Brouwer D. Exposure to manufactured nanoparticles in different workplaces. Toxicology. 2010;269:120-127.
6. Honnert B, Vincent R. Production et utilisation industrielle des particules nanostructurées. Hygiène et sécurité du travail - Cahiers de notes documentaires. 2007;209:5-21.
7. Sorahan T, Hamilton L, van TM, Gardiner K, Harrington JM. A cohort mortality study of U.K. carbon black workers, 1951-1996. Am J Ind Med. 2001;39:158-170.
8. Wellmann J, Weiland SK, Neiteler G, Klein G, Straif K. Cancer mortality in German carbon black workers 1976-98. Occup Environ Med. 2006;63:513-521.
9. Boffetta P, Soutar A, Cherrie JW et al. Mortality among workers employed in the titanium dioxide production industry in Europe. Cancer Causes Control. 2004;15:697-706. (Pubitemid 39060932)
10. Heinrich U, Fuhst R, Rittinghausen R et al. Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel exhaust, carbon black, and titanium dioxide. Inhal Toxicol. 1995;7:533-556.
11. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823-839. (Pubitemid 40984181)
12. Pope CA III, Dockery DW. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manag Assoc. 2006;56:709-742. (Pubitemid 43954090)
13. Poland CA, Duffin R, Kinloch I et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008;3:423-428.
14. Ryman-Rasmussen JP, Cesta MF, Brody AR et al. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol. 2009;4:747-751.
15. + /- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci. 2008;33:105-116.
16. Trout DB, Schulte PA. Medical surveillance, exposure registries, and epidemiologic research for workers exposed to nanomaterials. Toxicology. 2010;269:128-135.
17. Brook RD, Rajagopalan S, Pope CA, III CA et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331-2378.
18. Kreyling WG, Semmler M, Erbe F et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A. 2002;65:1513-1530. (Pubitemid 35217498)
19. Oberdorster G, Sharp Z, Atudorei V et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A. 2002;65:1531-1543. (Pubitemid 35217499)
20. Elder A, Gelein R, Silva V et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 2006;114:1172-1178. (Pubitemid 44184673)
21. Oberdorster G, Sharp Z, Atudorei V et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol. 2004;16:437-445. (Pubitemid 38685135)
22. Schulte PA, Schubauer-Berigan MK, Mayweather C, Geraci CL, Zumwalde R, McKernan JL. Issues in the development of epidemiologic studies of workers exposed to engineered nanoparticles. J Occup Environ Med. 2009;51:323-335.
23. Oberdorster G, Oberdorster E, Oberdorster J. Concepts of nanoparticle dose metric and response metric. Environ Health Perspect. 2007;115:A290. (Pubitemid 46902229)
24. Witschger O. Nanoparticules : quelles possibilités métrologiques pour caractériser l'exposition des personnes ? Spectra analyse. 2008;264:17-30.
25. Methner M, Hodson L, Geraci C. Nanoparticle emission assessment technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials - part A. J Occup Environ Hyg. 2010;7:127-132.